48 pending office actions • 24 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19115175 | FINGER SUPPORT THAT CAN BE ATTACHED TO AND REMOVED FROM FIREARMS | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | ABDOSH, SAMIR | 3641 | Non-Final OA | Mar 25, 2025 |
| 19061313 | INFORMATION-MARKET SYSTEM | Unknown | TROTTER, SCOTT S | 3696 | Non-Final OA | Feb 24, 2025 |
| 19005243 | COMPUTER-BASED SYSTEM AND METHOD FOR PORTFOLIO OPTIMIZATION | Efficient Tax LLC | POE, KEVIN T | 3692 | Non-Final OA | Dec 30, 2024 |
| 18869920 | A GRIP DESIGN WITH AN INSERT MANUFACTURED IN ONE PIECE BY INJECTION | Samsun Yurt Savunma Sanayi Ve Ticaret Anonim Sirketi | ELDRED, JOHN W | 3641 | Final Rejection | Nov 27, 2024 |
| 18956263 | SPACER FOR RESISTANCE ADJUSTMENT IN RESISTANCE TRAINING APPARATUS | Harambe System LLC | KOBYLARZ, ANDREW M | 3784 | Non-Final OA | Nov 22, 2024 |
| 18739123 | PRINTING FROM A HANDHELD DEVICE VIA A REMOTE SERVER | Quest Diagnostics Investments LLC | GUILLERMETY, JUAN M | 2682 | Non-Final OA | Jun 10, 2024 |
| 18571421 | Method and apparatus for wireless synchronization of mobile devices | Sennheiser Electronic GmbH & Co. Kg | DANIEL JR, WILLIE J | 2465 | Non-Final OA | Dec 18, 2023 |
| 18568249 | MACROCYCLIC TAK1 INHIBITORS | Aqilion AB | LEE, WILLIAM Y | 1623 | Non-Final OA | Dec 07, 2023 |
| 18287096 | FORMULATIONS OF CANNABINOIDS | Add Advanced Drug Delivery Technologies Ltd. | CHONG, YONG SOO | 1623 | Non-Final OA | Oct 16, 2023 |
| 18285063 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | TriSalus Life Sciences, Inc. | HUDSON, AMY ROSE | 1636 | Non-Final OA | Sep 29, 2023 |
| 18277861 | USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING A GALLBLADDER DISORDER | Nightingale Health Oyj | EPPERSON, JON D | 6211 | Non-Final OA | Aug 18, 2023 |
| 18277838 | USE OF GLYCOPROTEIN ACETYLS FOR DETERMINING THE RISK OF DEVELOPING ATRIAL FIBRILLATION AND/OR FLUTTER | Nightingale Health Oyj | GZYBOWSKI, MICHAEL STANLEY | 1798 | Non-Final OA | Aug 18, 2023 |
| 18233098 | METHODS OF DETERMINING POSITION OF A TARGET NODE IN SIDE-LINK COMMUNICATION SYSTEM | Indian Institute Of Technology Madras (Iit Madras) | LEE, SIU M | 2632 | Non-Final OA | Aug 11, 2023 |
| 18271573 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MENTAL AND/OR A BEHAVIOURAL DISORDER | Nightingale Health Oyj | WECKER, JENNIFER | 1797 | Non-Final OA | Jul 10, 2023 |
| 18216174 | Loudspeaker Power Amplifier and Loudspeaker | Sennheiser Electronic GmbH & Co. Kg | NGUYEN, KHANH V | 2843 | Non-Final OA | Jun 29, 2023 |
| 18212459 | Mobile Wireless Audio Transmission System and Charging/Transport Dock | Sennheiser Electronic GmbH & Co. Kg | TRISCHLER, JOHN T | 2859 | Non-Final OA | Jun 21, 2023 |
| 18267956 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MUSCULOSKELETAL AND/OR CONNECTIVE TISSUE DISEASE | Nightingale Health Oyj | PAPCIAK, SHARON M | 1657 | Non-Final OA | Jun 16, 2023 |
| 18039883 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING AN ANEMIA AND/OR A METABOLIC CONDITION RELATED TO THE NUTRITIONAL STATE AND/OR FLUID BALANCE OF THE BLOOD | Nightingale Health Oyj | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Jun 01, 2023 |
| 18036733 | METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DETERMINING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR COLLECTING DATA FOR USE IN DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, METHOD FOR DIAGNOSING SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, IN VITRO METHOD FOR ASSISTING DETERMINATION ON SUITABILITY OF ESOPHAGEAL CANCER FOR ENDOSCOPIC THERAPY, ... | Public University Corporation Nagoya City University | BUCHANAN, BAILEY CHEYENNE | 1682 | Non-Final OA | May 12, 2023 |
| 18131759 | BLADDER TISSUE MODIFICATION FOR OVERACTIVE BLADDER DISORDERS | Newuro, B.V. | PEFFLEY, MICHAEL F | 3794 | Final Rejection | Apr 06, 2023 |
| 18027883 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | TriSalus Life Sciences, Inc. | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Mar 22, 2023 |
| 18027895 | CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS | TriSalus Life Sciences, Inc. | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Mar 22, 2023 |
| 18027874 | BIOMARKERS | Genome Research Limited | GOLDBERG, JEANINE ANNE | 1682 | Non-Final OA | Mar 22, 2023 |
| 18087508 | SYSTEMS AND METHODS FOR SELECTIVELY INDUCING VASOCONSTRICTION TO INCREASE THERAPEUTIC UPTAKE IN TISSUE | TriSalus Life Sciences, Inc. | JIAN, SHIRLEY XUEYING | 3792 | Non-Final OA | Dec 22, 2022 |
| 18087767 | SYSTEMS AND METHODS FOR CONTROLLING FLOW OF THERAPEUTIC AGENT DELIVERED TO AN INFUSION CATHETER | TriSalus Life Sciences, Inc. | PATEL, SHEFALI DILIP | 3783 | Non-Final OA | Dec 22, 2022 |
| 18011082 | METHOD FOR DETERMINING WHETHER A SUBJECT HAS A DISEASE OR CONDITION OR IS AT RISK OF DEVELOPING A DISEASE OR CONDITION | Nightingale Health Oyj | FRITCHMAN, REBECCA M | 1758 | Final Rejection | Dec 16, 2022 |
| 17990634 | DEVICES AND METHODS FOR TRANSURETHRAL BLADDER PARTITIONING | Newuro, B.V. | PEFFLEY, MICHAEL F | 3794 | Final Rejection | Nov 18, 2022 |
| 17984611 | DPP3 BINDER DIRECTED TO AND BINDING TO SPECIFIC DPP3-EPITOPES AND ITS USE IN THE PREVENTION OR TREATMENT OF DISEASES/ACUTE CONDITIONS THAT ARE ASSOCIATED WITH OXIDATIVE STRESS | 4TEEN4 Pharmaceuticals GmbH | WEN, SHARON X | 1641 | Non-Final OA | Nov 10, 2022 |
| 17923786 | Uses and Formulations of Cannabinoids | Add Advanced Drug Delivery Technologies Ltd. | LEE, WILLIAM Y | 1623 | Non-Final OA | Nov 07, 2022 |
| 17923754 | Uses and Formulations of Cannabinoids | Add Advanced Drug Delivery Technologies Ltd. | HSU, GRACE CHING | 1627 | Non-Final OA | Nov 07, 2022 |
| 17953152 | DEVICES AND METHOD FOR FAR FIELD BIPOLAR ABLATION | Newuro, B.V. | SHOULDERS, ANNIE LEE | 3794 | Final Rejection | Sep 26, 2022 |
| 17951874 | TISSUE HOMOGENIZATION BUFFER FOR EFFICIENT QUANTITATION OF A THERAPEUTIC OLIGONUCLEOTIDE IN MULTIPLE TISSUES | TriSalus Life Sciences, Inc. | POHNERT, STEVEN C | 1683 | Non-Final OA | Sep 23, 2022 |
| 17911819 | DPP3 IN PATIENTS INFECTED WITH CORONAVIRUS | 4TEEN4 Pharmaceuticals GmbH | WEN, SHARON X | 1641 | Non-Final OA | Sep 15, 2022 |
| 17802799 | DPP3 FOR THERAPY GUIDANCE, MONITORING AND STRATIFICATION OF NT-ADM ANTIBODIES IN PATIENTS WITH SHOCK | 4TEEN4 Pharmaceuticals GmbH | AEDER, SEAN E | 1642 | Final Rejection | Aug 26, 2022 |
| 17840812 | PROCESS TECHNOLOGY FOR BIOLOGICAL PRODUCT MANUFACTURING AND DOWNSTREAM PURIFICATION | Enquyst Technologies Inc. | BASS, DIRK R | 1779 | Final Rejection | Jun 15, 2022 |
| 17602356 | PROCESS FOR CONTINUOUS PRODUCTION OF AN ACTIVE INGREDIENT GRANULATE | Add Advanced Drug Delivery Technologies Ltd. | JANOSKO, CHASITY PAIGE | 1613 | Final Rejection | May 25, 2022 |
| 17770974 | PROSTATE CANCER DETECTION METHODS | Cancer Research Technology Limited | SCHLOOP, ALLISON ELIZABETH | 1683 | Final Rejection | Apr 21, 2022 |
| 17769398 | CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES | Add Advanced Drug Delivery Technologies Ltd. | BAEK, BONG-SOOK | 1611 | Final Rejection | Apr 15, 2022 |
| 17769424 | CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES | Add Advanced Drug Delivery Technologies Ltd. | YOUNG, MICAH PAUL | 1618 | Final Rejection | Apr 15, 2022 |
| 17622187 | DIGITAL CERTIFICATE PROCESSING METHOD, GATEWAY, DEVICE, SYSTEM, MEDIUM, AND PROGRAM PRODUCT | Antpool Technologies Limited | QAYYUM, ZESHAN | 3697 | Non-Final OA | Dec 22, 2021 |
| 17557132 | THERAPEUTIC PILLOW | Invicta Watch Company Of America, Inc. | SUN, GEORGE | 3673 | Non-Final OA | Dec 21, 2021 |
| 17610127 | METHODS AND SYSTEMS FOR PROTEIN ENGINEERING AND PRODUCTION | Labgenius Ltd. | PLAYER, ROBERT AUSTIN | 1686 | Non-Final OA | Nov 09, 2021 |
| 17416197 | THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR A TREATMENT WITH ANGIOTENSIN-RECEPTOR-AGONIST AND/OR A PRECURSOR THEREOF | 4TEEN4 Pharmaceuticals GmbH | RAMADAN, OMAR | 1678 | Non-Final OA | Jun 18, 2021 |
| 17236446 | Atraumatic Occlusive System with Compartment for Measurement of Vascular Pressure Change | TriSalus Life Sciences, Inc. | MEDWAY, SCOTT J | 3783 | Non-Final OA | Apr 21, 2021 |
| 17187652 | FLEXIBLE BIPOLAR ELECTRODE AND METHODS OF MANUFACTURING AND USE FOR TREATING MEDICAL CONDITIONS INCLUDING OBESITY AND CONSTIPATION | Newuro, B.V. | RHODES, NORA W | 3794 | Non-Final OA | Feb 26, 2021 |
| 16513238 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | Glatt GmbH | ALAM, AYAAN A | 1611 | Non-Final OA | Jul 16, 2019 |
| 16513068 | EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS | Glatt GmbH | ALAM, AYAAN A | 1611 | Final Rejection | Jul 16, 2019 |
| 15955508 | POWDER DISPERSION DEVICES AND METHODS | Respira Therapeutics, Inc. | WOLFF, ARIELLE R | 3785 | Final Rejection | Apr 17, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial